Combined Amphiregulin and Epiregulin Expression As a Prognostic and Predictive Biomarker of Panitumumab (pmab), Fluorouracil, and Folinic Acid (FU/FA) or FU/FA Maintenance Therapy Following Pmab+FOLFOX Induction in RAS Wildtype Metastatic Colorectal Cancer (mcrc): PANAMA Trial (AIO-KRK-0212).
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined